The Great Conversation: How Do We Decide Which Risks Are Worth Taking?
Hello everyone, and welcome to The Great Conversation.
Few medications have generated as much public debate as statins.
They are among the most widely prescribed drugs in the world, used primarily to lower LDL cholesterol and reduce the risk of heart attacks and strokes.
They have also accumulated a long list of alleged side effects.
Muscle pain.
Memory problems.
Depression.
Sleep problems.
Sexual dysfunction.
Diabetes.
Liver problems.
And many others.
For someone deciding whether to take a medication every day, that list can understandably sound alarming.
But a recent Telegraph article explores research that complicates that picture.
A major analysis published in The Lancet examined randomized clinical trial evidence surrounding 66 different health conditions or symptoms that have been attributed to statins.
Researchers found convincing evidence supporting only a small number of those associations.
That does not mean statins have no side effects.
They do.
The evidence indicates, for example, a small increase in the risk of developing diabetes, changes in liver enzymes, and some muscle-related symptoms.
But many other problems commonly associated with statins were not supported by the randomized evidence examined.
And this creates an interesting problem.
How should we think about risk?
Suppose a medication reduces your chance of experiencing a heart attack but slightly increases your chance of developing another condition.
Is that medication safe?
The answer cannot be found simply by asking whether the drug has side effects.
Almost every effective medical treatment carries some possibility of harm.
The more meaningful question is whether the expected benefit outweighs the expected risk.
And that calculation may be very different from one person to another.
Someone who has already suffered a heart attack or stroke may face a substantial risk of another cardiovascular event.
For that person, even a medication with some potential side effects may offer an important benefit.
But someone with a much lower cardiovascular risk may face a different calculation.
The medication has not changed.
The person has.
And therefore the meaning of the risk has changed too.
This reveals something important about the way medical information is often communicated.
We like simple categories.
Safe.
Dangerous.
Healthy.
Unhealthy.
Good.
Bad.
But medicine frequently refuses to cooperate with those categories.
A treatment can be beneficial and still carry risks.
A side effect can be real and still be rare.
A medication can make sense for one person and make much less sense for another.
And a tiny statistical risk can feel completely different depending on which side of the statistic you happen to occupy.
If a serious side effect occurs in one person out of thousands, researchers may reasonably describe that risk as very small.
But if you are that one person, the experience is not small at all.
This is where population statistics meet individual lives.
Medicine must study large groups because that is how researchers discover whether treatments generally work.
But doctors ultimately treat individuals.
And individuals bring histories that statistics alone cannot capture completely.
Age.
Family history.
Previous illnesses.
Other medications.
Lifestyle.
Personal priorities.
Tolerance for uncertainty.
Even the question of what risk someone fears most.
One person may fear a heart attack far more than the possibility of medication side effects.
Another may have previously experienced severe side effects and therefore approach the same medication very differently.
Neither person experiences risk as an abstract percentage.
Risk becomes personal.
There is another complication.
Our perception of risk is not formed only by scientific evidence.
Stories matter.
If someone we know begins taking a medication and soon experiences muscle pain, that story may influence us more strongly than a study involving thousands of people.
That is understandable.
Human beings experience stories directly.
Statistics are abstractions.
But stories have limitations too.
Something happening after taking a medication does not necessarily mean the medication caused it.
People taking medications also experience headaches, fatigue, memory problems, muscle aches, insomnia, and countless other symptoms for reasons completely unrelated to the medication.
Separating coincidence from causation is one of the reasons randomized clinical trials exist.
Yet scientific evidence has its own limitations.
Studies describe probabilities.
They do not predict with certainty what will happen to a particular person.
Science may tell us that a complication is rare.
It cannot promise that we will not experience it.
And that leaves us with uncertainty.
Perhaps that is the part of medical decision-making we find hardest to accept.
We often want medicine to give us certainty.
Take this.
Avoid that.
Eat this.
Don't eat that.
This treatment is safe.
That treatment is dangerous.
But evidence rarely speaks with such absolute clarity.
Instead, it gives us probabilities.
This treatment reduces this risk by approximately this amount.
It may increase another risk by approximately this amount.
Here is what we know.
Here is what remains uncertain.
And then someone has to decide.
That decision becomes especially difficult when public discussion turns medical questions into opposing camps.
Pro-medication.
Anti-medication.
Trust medicine.
Distrust medicine.
But perhaps those categories obscure the real question.
The goal is not to be for or against a medication.
The goal is to understand the evidence well enough to make an informed decision about a particular person in a particular situation.
That requires something more difficult than certainty.
It requires judgment.
It requires asking how large the benefit actually is.
How large the risk actually is.
How reliable the evidence is.
Whether alternatives exist.
And how all of those things apply to the individual sitting in front of the decision.
The debate surrounding statins therefore points toward something much larger than cholesterol.
Modern medicine increasingly gives us the ability to measure risk.
But measuring risk does not eliminate the need to interpret it.
A 1 percent risk can sound frightening or reassuring depending on how it is presented.
A 20 percent reduction in risk can sound enormous until we understand what the original risk was.
And a rare side effect can appear insignificant statistically while remaining deeply significant to the person experiencing it.
Numbers help us understand reality.
But they do not make decisions for us.
Which raises a deeper question...
When every medical choice carries some combination of benefit, risk, and uncertainty, how should we decide which risks are worth taking?
Take a moment to reflect.
And click the link below to see more on this subject.
